XML 65 R23.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATION
3 Months Ended
Mar. 31, 2025
Condensed Financial Information Disclosure [Abstract]  
CONSOLIDATION
15. CONSOLIDATION
Investments in Consolidated Variable Interest Entities

The Company consolidates entities in which the Company has a variable interest and as the general partner or investment manager, has both the power to direct the most significant activities and a potentially significant economic interest. Investments in the consolidated variable interest entities (“VIEs”) are reported at fair value and represent the Company’s maximum exposure to loss.

Investments in Non-Consolidated Variable Interest Entities

The Company holds interests in certain VIEs that are not consolidated as the Company is not the primary beneficiary. The Company’s interest in such entities generally is in the form of direct equity interests, fixed fee arrangements or both. The maximum exposure to loss represents the potential loss of assets by the Company relating to its direct investments in these non-consolidated entities. Investments in the non-consolidated VIEs are carried at fair value.

The Company’s interests in consolidated and non-consolidated VIEs, as presented within the Condensed Consolidated Statements of Financial Condition, its respective maximum exposure to loss relating to non-consolidated VIEs, and its net income attributable to non-controlling interests related to consolidated VIEs, as presented within the Condensed Consolidated Statements of Operations, are as follows:
As of March 31,As of December 31,
20252024
Maximum exposure to loss attributable to the Company’s investment in non-consolidated VIEs
$481,856 $386,927 
Maximum exposure to loss attributable to the Company’s investment in consolidated VIEs831,767 791,133 
Assets of consolidated VIEs
12,804,566 13,698,611 
Liabilities of consolidated VIEs
9,805,049 10,879,735 

Three months ended March 31,
20252024
Net income attributable to non-controlling interests related to consolidated VIEs$52,976 $58,356 
Consolidating Schedules
The following supplemental financial information illustrates the consolidating effects of the Consolidated Funds on the Company’s financial condition, results from operations and cash flows:
 As of March 31, 2025
 Consolidated
Company Entities 
Consolidated
Funds 
Eliminations Consolidated 
Assets    
Cash and cash equivalents$618,536 $— $— $618,536 
Investments (includes $3,557,277 of accrued carried interest)
5,786,946 — (894,657)4,892,289 
Due from affiliates1,146,479 — (23,689)1,122,790 
Other assets863,339 — — 863,339 
Right-of-use operating lease assets546,814 — — 546,814 
Intangible assets, net2,276,847 — — 2,276,847 
Goodwill3,499,341 — — 3,499,341 
Assets of Consolidated Funds
Cash and cash equivalents— 1,184,275 — 1,184,275 
Investments held in trust account— 556,498 — 556,498 
Investments, at fair value— 11,419,808 — 11,419,808 
Receivable for securities sold— 142,902 — 142,902 
Other assets— 58,329 — 58,329 
Total assets$14,738,302 $13,361,812 $(918,346)$27,181,768 
Liabilities    
Accounts payable, accrued expenses and other liabilities$856,109 $— $(278)$855,831 
Accrued compensation300,756 — — 300,756 
Due to affiliates721,848 — — 721,848 
Performance related compensation payable2,599,227 — — 2,599,227 
Debt obligations3,544,527 — — 3,544,527 
Operating lease liabilities686,038 — — 686,038 
Liabilities of Consolidated Funds
Accounts payable, accrued expenses and other liabilities— 141,625 (672)140,953 
Due to affiliates— 22,521 (22,521)— 
Payable for securities purchased— 415,332 — 415,332 
CLO loan obligations, at fair value— 8,647,925 (125,923)8,522,002 
Fund borrowings— 603,307 — 603,307 
Total liabilities8,708,505 9,830,710 (149,394)18,389,821 
Commitments and contingencies
Redeemable interest in Consolidated Funds 556,398  556,398 
Redeemable interest in Ares Operating Group entities23,710   23,710 
Non-controlling interest in Consolidated Funds 2,974,704 (834,660)2,140,044 
Non-controlling interest in Ares Operating Group entities1,595,930  21,758 1,617,688 
Stockholders’ Equity
Series B mandatory convertible preferred stock, $0.01 par value, 1,000,000,000 shares authorized (30,000,000 shares issued and outstanding)
1,459,918 — — 1,459,918 
Class A common stock, $0.01 par value, 1,500,000,000 shares authorized (214,895,604 shares issued and outstanding)
2,149 — — 2,149 
Non-voting common stock, $0.01 par value, 500,000,000 shares authorized (3,489,911 shares issued and outstanding)
35 — — 35 
Class B common stock, $0.01 par value, 1,000 shares authorized (1,000 shares issued and outstanding)
— — — — 
Class C common stock, $0.01 par value, 499,999,000 shares authorized (108,114,920 shares issued and outstanding)
1,081 — — 1,081 
Additional paid-in-capital3,996,758 — 43,950 4,040,708 
Accumulated deficit(1,074,128)— — (1,074,128)
Accumulated other comprehensive loss, net of tax24,344 — — 24,344 
       Total stockholders’ equity4,410,157  43,950 4,454,107 
       Total equity6,006,087 2,974,704 (768,952)8,211,839 
 Total liabilities, redeemable interest, non-controlling interests and equity$14,738,302 $13,361,812 $(918,346)$27,181,768 
 As of December 31, 2024
 Consolidated
Company Entities 
Consolidated
Funds 
EliminationsConsolidated 
Assets    
Cash and cash equivalents$1,507,976 $— $— $1,507,976 
Investments (includes $3,495,115 of accrued carried interest)
5,485,012 — (840,237)4,644,775 
Due from affiliates1,236,450 — (179,842)1,056,608 
Other assets774,654 — — 774,654 
Right-of-use operating lease assets511,319 — — 511,319 
Intangible assets, net975,828 — — 975,828 
Goodwill1,162,636 — — 1,162,636 
Assets of Consolidated Funds
Cash and cash equivalents— 1,227,489 — 1,227,489 
Investments held in trust account— 550,800 — 550,800 
Investments, at fair value— 12,187,044 — 12,187,044 
Receivable for securities sold— 202,782 202,782 
Other assets— 82,397 82,397 
Total assets$11,653,875 $14,250,512 $(1,020,079)$24,884,308 
Liabilities    
Accounts payable, accrued expenses and other liabilities$364,152 $— $(280)$363,872 
Accrued compensation280,894 — — 280,894 
Due to affiliates500,480 — — 500,480 
Performance related compensation payable2,537,203 — — 2,537,203 
Debt obligations2,558,914 — — 2,558,914 
Operating lease liabilities641,864 — — 641,864 
Liabilities of Consolidated Funds
Accounts payable, accrued expenses and other liabilities— 323,566 (466)323,100 
Due to affiliates— 178,409 (178,409)— 
Payable for securities purchased— 332,406 — 332,406 
CLO loan obligations, at fair value— 9,793,645 (121,456)9,672,189 
Fund borrowings— 275,000 — 275,000 
Total liabilities6,883,507 10,903,026 (300,611)17,485,922 
Commitments and contingencies
Redeemable interest in Consolidated Funds 550,700  550,700 
Redeemable interest in Ares Operating Group entities23,496   23,496 
Non-controlling interest in Consolidated Funds 2,796,786 (771,120)2,025,666 
Non-controlling interest in Ares Operating Group entities1,236,767  18,111 1,254,878 
Stockholders’ Equity
Series B mandatory convertible preferred stock, $0.01 par value, 1,000,000,000 shares authorized (30,000,000 shares issued and outstanding)
1,458,771 — — 1,458,771 
Class A common stock, $0.01 par value, 1,500,000,000 shares authorized (199,872,571 shares issued and outstanding)
1,999 — — 1,999 
Non-voting common stock, $0.01 par value, 500,000,000 shares authorized (3,489,911 shares issued and outstanding)
35 — — 35 
Class B common stock, $0.01 par value, 1,000 shares authorized ($1,000 shares issued and outstanding)
— — — — 
Class C common stock, $0.01 par value, 499,999,000 shares authorized (109,806,689 shares issued and outstanding)
1,098 — — 1,098 
Additional paid-in-capital2,903,253 — 33,541 2,936,794 
Accumulated deficit(837,294)— — (837,294)
Accumulated other comprehensive loss, net of tax(17,757)— — (17,757)
       Total stockholders’ equity3,510,105  33,541 3,543,646 
       Total equity4,746,872 2,796,786 (719,468)6,824,190 
       Total liabilities, redeemable interest, non-controlling interests and equity$11,653,875 $14,250,512 $(1,020,079)$24,884,308 
 
Three months ended March 31, 2025
 Consolidated
Company Entities 
Consolidated
Funds 
Eliminations Consolidated
Revenues    
Management fees$826,881 $— $(9,894)$816,987 
Carried interest allocation165,126 — (5,118)160,008 
Incentive fees32,058 — (10)32,048 
Principal investment income26,839 — (4,841)21,998 
Administrative, transaction and other fees57,888 — (124)57,764 
Total revenues1,108,792  (19,987)1,088,805 
Expenses    
Compensation and benefits657,125 — — 657,125 
Performance related compensation122,633 — — 122,633 
General, administrative and other expense227,914 — — 227,914 
Expenses of the Consolidated Funds— 16,684 (10,028)6,656 
Total expenses1,007,672 16,684 (10,028)1,014,328 
Other income (expense)    
Net realized and unrealized gains on investments10,631 — (10,363)268 
Interest and dividend income18,203 — (547)17,656 
Interest expense(36,387)— — (36,387)
Other expense, net(10,508)— (206)(10,714)
Net realized and unrealized gains on investments of the Consolidated Funds— 83,727 4,679 88,406 
Interest and other income of the Consolidated Funds— 160,072 — 160,072 
Interest expense of the Consolidated Funds— (157,377)4,637 (152,740)
Total other income (expense), net(18,061)86,422 (1,800)66,561 
Income before taxes83,059 69,738 (11,759)141,038 
Income tax expense15,535 2,002 — 17,537 
Net income67,524 67,736 (11,759)123,501 
Less: Net income attributable to non-controlling interests in Consolidated Funds— 67,736 (11,759)55,977 
Net income attributable to Ares Operating Group entities67,524   67,524 
Less: Net income attributable to redeemable interest in Ares Operating Group entities316 — — 316 
Less: Net income attributable to non-controlling interests in Ares Operating Group entities20,038 — — 20,038 
Net income attributable to Ares Management Corporation47,170   47,170 
Less: Series B mandatory convertible preferred stock dividends declared25,313   25,313 
Net income attributable to Ares Management Corporation Class A and non-voting common stockholders$21,857 $ $ $21,857 
 Three months ended March 31, 2024
 Consolidated
Company Entities 
Consolidated
Funds 
EliminationsConsolidated 
Revenues    
Management fees$700,145 $— $(12,453)$687,692 
Carried interest allocation(26,550)— (5,928)(32,478)
Incentive fees8,664 — 8,667 
Principal investment income (loss)(2,665)— 9,715 7,050 
Administrative, transaction and other fees36,545 — (113)36,432 
Total revenues716,139  (8,776)707,363 
Expenses
Compensation and benefits412,951 — — 412,951 
Performance related compensation(50,532)— — (50,532)
General, administrative and other expense171,361 — (433)170,928 
Expenses of the Consolidated Funds— 17,708 (12,562)5,146 
Total expenses533,780 17,708 (12,995)538,493 
Other income (expense)
Net realized and unrealized gains on investments12,357 — (1,841)10,516 
Interest and dividend income8,092 — (2,710)5,382 
Interest expense(37,824)— — (37,824)
Other income, net478 — (208)270 
Net realized and unrealized gains on investments of the Consolidated Funds— 32,352 2,072 34,424 
Interest and other income of the Consolidated Funds— 257,067 209 257,276 
Interest expense of the Consolidated Funds— (209,442)1,576 (207,866)
Total other income (expense), net(16,897)79,977 (902)62,178 
Income before taxes165,462 62,269 3,317 231,048 
Income tax expense (benefit)28,363 (1,130)— 27,233 
Net income137,099 63,399 3,317 203,815 
Less: Net income attributable to non-controlling interests in Consolidated Funds— 63,399 3,317 66,716 
Net income attributable to Ares Operating Group entities137,099   137,099 
Less: Net income attributable to redeemable interest in Ares Operating Group entities73 — — 73 
Less: Net income attributable to non-controlling interests in Ares Operating Group entities63,999 — — 63,999 
Net income attributable to Ares Management Corporation Class A and non-voting common stockholders$73,027 $ $ $73,027 
 
Three months ended March 31, 2025
 Consolidated
Company Entities 
Consolidated
Funds
EliminationsConsolidated
Cash flows from operating activities:  
Net income$67,524 $67,736 $(11,759)$123,501 
Adjustments to reconcile net income to net cash provided by operating activities267,697  42,636 310,333 
Adjustments to reconcile net income to net cash provided by operating activities allocable to non-controlling interests in Consolidated Funds— 980,313 (11,344)968,969 
Cash flows due to changes in operating assets and liabilities372,073  (144,367)227,706 
Cash flows due to changes in operating assets and liabilities allocable to non-controlling interest in Consolidated Funds 164,586 199,108 363,694 
Net cash provided by operating activities707,294 1,212,635 74,274 1,994,203 
Cash flows from investing activities: 
Purchase of furniture, equipment and leasehold improvements, net of disposals(21,975)— — (21,975)
Acquisitions, net of cash acquired(1,722,715)— — (1,722,715)
Net cash used in investing activities(1,744,690)  (1,744,690)
Cash flows from financing activities: 
Net proceeds from issuance of Series B mandatory convertible preferred stock— — — — 
Net proceeds from issuance of Class A common stock— — — — 
Proceeds from Credit Facility1,125,000 — — 1,125,000 
Repayments of Credit Facility(140,000)— — (140,000)
Dividends and distributions (445,088)— — (445,088)
Taxes paid related to net share settlement of equity awards(396,722)— — (396,722)
Other financing activities457 — — 457 
Allocable to redeemable and non-controlling interests in Consolidated Funds:
Contributions from redeemable and non-controlling interests in Consolidated Funds— 123,707 (34,627)89,080 
Distributions to non-controlling interests in Consolidated Funds— (321,741)3,567 (318,174)
Borrowings under loan obligations by Consolidated Funds— 172,606 — 172,606 
Repayments under loan obligations by Consolidated Funds— (1,264,886)— (1,264,886)
Net cash provided by (used in) financing activities143,647 (1,290,314)(31,060)(1,177,727)
Effect of exchange rate changes4,309 34,465 — 38,774 
Net change in cash and cash equivalents(889,440)(43,214)43,214 (889,440)
Cash and cash equivalents, beginning of period1,507,976 1,227,489 (1,227,489)1,507,976 
Cash and cash equivalents, end of period$618,536 $1,184,275 $(1,184,275)$618,536 
Supplemental disclosure of non-cash financing activities:
Equity issued in connection with acquisition-related activities$1,657,881 $— $— $1,657,881 
 Three months ended March 31, 2024
Consolidated
Company Entities 
Consolidated
Funds
EliminationsConsolidated
Cash flows from operating activities:  
Net income$137,099 $63,399 $3,317 $203,815 
Adjustments to reconcile net income to net cash provided by operating activities224,720 — (1,724)222,996 
Adjustments to reconcile net income to net cash provided by operating activities allocable to non-controlling interests in Consolidated Funds— 246,254 (2,072)244,182 
Cash flows due to changes in operating assets and liabilities96,544 — 7,437 103,981 
Cash flows due to changes in operating assets and liabilities allocable to non-controlling interest in Consolidated Funds— (14,577)(50,352)(64,929)
Net cash provided by operating activities458,363 295,076 (43,394)710,045 
Cash flows from investing activities: 
Purchase of furniture, equipment and leasehold improvements, net of disposals(26,071)— — (26,071)
Acquisitions, net of cash acquired(8,000)— — (8,000)
Net cash used in investing activities(34,071)  (34,071)
Cash flows from financing activities: 
Proceeds from Credit Facility290,000 — — 290,000 
Repayments of Credit Facility(210,000)— — (210,000)
Dividends and distributions (320,046)— — (320,046)
Stock option exercises1,511 — — 1,511 
Taxes paid related to net share settlement of equity awards(186,731)— — (186,731)
Other financing activities1,034 — — 1,034 
Allocable to non-controlling interests in Consolidated Funds: 
Contributions from non-controlling interests in Consolidated Funds— 180,559 (11,886)168,673 
Distributions to non-controlling interests in Consolidated Funds— (32,323)5,415 (26,908)
Borrowings under loan obligations by Consolidated Funds— 36,947 — 36,947 
Repayments under loan obligations by Consolidated Funds— (421,112)— (421,112)
Net cash used in financing activities(424,232)(235,929)(6,471)(666,632)
Effect of exchange rate changes(2,003)(9,282)— (11,285)
Net change in cash and cash equivalents(1,943)49,865 (49,865)(1,943)
Cash and cash equivalents, beginning of period348,274 1,149,511 (1,149,511)348,274 
Cash and cash equivalents, end of period$346,331 $1,199,376 $(1,199,376)$346,331 
Supplemental disclosure of non-cash financing activities:
Equity issued in connection with acquisition-related activities$7,724 $— $— $7,724